{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:52:21Z","timestamp":1791431541206,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-005318"],"award-info":[{"award-number":["INV-005318"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To estimate the proportion RSV-positive among children aged\u2009&lt;\u20095\u00a0years hospitalized with ARI in low- and middle-income countries (LMIC), where 97% of RSV mortality occurs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic literature search for studies conducted pre-COVID-19 and published 2010\u20142022 (PROSPERO registration CRD42022361351). We estimated the RSV percent positivity and 95% confidence interval (CI) using random-effects meta-analyses. We assessed heterogeneity in RSV percent positivity using subgroup analyses and univariable meta-regression models. We assessed the influence of study sample size in sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-three studies conducted in 37 LMICs were included. The summary estimate of percent RSV-positive from the meta-analysis of children\u2009&lt;\u20095\u00a0years hospitalized with ARI was 26.2% (95% CI: 24.3\u201328.3%), ranging from 18.9% (16.4\u201321.6%) among children 6\u2013\u2009&lt;\u200960\u00a0months to 41.3% (36.4\u201346.4%) among children 0\u2013\u2009&lt;\u20096\u00a0months. Only five studies included children aged\u2009&lt;\u20092\u00a0months, but RSV positivity was high among this group (40.2% [35.8\u201344.7%]). Percent positivity stratified by WHO region ranged from 23.6% in the Africa and Southeast Asian regions to 37.5% in the European region. RSV positivity was similar across country income groups. Univariable meta-regression models indicated that there was significant heterogeneity in RSV percent positivity across subgroups defined by mid-year of the study period, WHO region, number of study sites, recruitment method, hospital type, and specimen type (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RSV detection was high among children aged\u2009&lt;\u20095\u00a0years hospitalized with ARI in LMICs across all WHO regions, especially among infants aged\u2009&lt;\u20096\u00a0months, among whom RSV may account for almost up to one-half of all ARI hospital admissions. Recent WHO-recommended RSV immunization for all countries may protect young infants aged\u2009&lt;\u20096\u00a0months against severe RSV disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-26743-4","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:05:15Z","timestamp":1771909515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Respiratory syncytial virus positivity among hospital admissions for acute respiratory illness in children younger than 5\u00a0years of age in low- and middle-income countries: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Chelsea S.","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Deloria","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin G.","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Feikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"10340","key":"26743_CR1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047\u201364.","journal-title":"Lancet"},{"issue":"10200","key":"26743_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","volume":"394","author":"Pneumonia Etiology Research for Child Health (PERCH) Study Group","year":"2019","unstructured":"Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019;394(10200):757\u201379.","journal-title":"Lancet"},{"issue":"16","key":"26743_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann B, Madhi SA, Munjal I, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023;388(16):1451\u201364.","journal-title":"N Engl J Med"},{"issue":"3","key":"26743_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"EAF Sim\u00f5es","year":"2023","unstructured":"Sim\u00f5es EAF, Madhi SA, Muller WJ, et al. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health. 2023;7(3):180\u20139.","journal-title":"Lancet Child Adolesc Health"},{"key":"26743_CR5","unstructured":"Gavi, the Vaccine Alliance. Vaccine Investment Strategy. 2018. https:\/\/www.gavi.org\/sites\/default\/files\/board\/minutes\/2018\/28-nov\/docs\/08%20-%20Vaccine%20Investment%20Strategy%20document.pdf (accessed 15 Jan 2025)."},{"issue":"Suppl_3","key":"26743_CR6","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1093\/cid\/ciab486","volume":"73","author":"P Srikantiah","year":"2021","unstructured":"Srikantiah P, Vora P, Klugman KP. Assessing the full burden of respiratory syncytial virus in young infants in low- and middle-income countries: the importance of community mortality studies. Clin Infect Dis. 2021;73(Suppl_3):S177\u20139.","journal-title":"Clin Infect Dis"},{"key":"26743_CR7","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"26743_CR8","unstructured":"World Health Organization. Integrated management of childhood illness. 2018. https:\/\/www.who.int\/teams\/maternal-newborn-child-adolescent-health-and-ageing\/child-health\/integrated-management-of-childhood-illness (accessed 08 Apr 2025)."},{"key":"26743_CR34","doi-asserted-by":"publisher","unstructured":"Leija-Mart\u00ednez JJ, Esparza-Miranda LA, Rivera-Alfaro G, et al. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Viruses. 2024;16(3):429. https:\/\/doi.org\/10.3390\/v16030429.","DOI":"10.3390\/v16030429"},{"key":"26743_CR10","unstructured":"The World Bank. The World by Income and Region. 2025. https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html (accessed March 03 2024)."},{"issue":"3","key":"26743_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","volume":"3","author":"Z Munn","year":"2014","unstructured":"Munn Z, Moola S, Riitano D, et al. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123\u20138.","journal-title":"Int J Health Policy Manag"},{"issue":"11","key":"26743_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, et al. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138.","journal-title":"J Epidemiol Community Health"},{"issue":"Pt A","key":"26743_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139\u201345.","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"26743_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1214\/aoms\/1177729756","volume":"21","author":"MF Freeman","year":"1950","unstructured":"Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21(4):607\u201311.","journal-title":"Ann Math Stat"},{"key":"26743_CR15","unstructured":"World Health Organization. Countries\/areas by WHO region. 2015. https:\/\/apps.who.int\/violence-info\/Countries%20and%20areas%20by%20WHO%20region%20-%2012bfe12.pdf."},{"key":"26743_CR16","unstructured":"United Nations Development Programme. Human Development report. 2025. https:\/\/hdr.undp.org\/data-center\/human-development-index#\/indicies\/HDI (accessed 10 Mar 2025)."},{"issue":"2","key":"26743_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112\u201325.","journal-title":"Res Synth Methods"},{"issue":"8","key":"26743_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jclinepi.2014.03.003","volume":"67","author":"JP Hunter","year":"2014","unstructured":"Hunter JP, Saratzis A, Sutton AJ, et al. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J Clin Epidemiol. 2014;67(8):897\u2013903.","journal-title":"J Clin Epidemiol"},{"key":"26743_CR19","unstructured":"PATH. RSV vaccine and mAb snapshot. 2025. https:\/\/www.path.org\/our-impact\/resources\/rsv-vaccine-and-mab-snapshot\/ (accessed 15 Mar 2025)."},{"issue":"4","key":"26743_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/cid\/cix378","volume":"65","author":"T B\u00e9net","year":"2017","unstructured":"B\u00e9net T, S\u00e1nchez Picot V, Messaoudi M, et al. Microorganisms associated with pneumonia in children <5 years of age in developing and emerging countries: The GABRIEL Pneumonia multicenter, prospective. Case-Control Study Clin Infect Dis. 2017;65(4):604\u201312.","journal-title":"Case-Control Study Clin Infect Dis"},{"key":"26743_CR21","unstructured":"University of Cape Town. The Drakenstein Child Health Study (DCHS). 2025. https:\/\/health.uct.ac.za\/department-paediatrics\/research-about-research-department-research-units-mrc-unit-child-and-adolescent-health\/drakenstein-child-health-study-dchs (accessed 16 Mar 2025)."},{"issue":"10","key":"26743_CR22","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1016\/S2214-109X(20)30251-5","volume":"8","author":"HJ Zar","year":"2020","unstructured":"Zar HJ, Nduru P, Stadler JAM, et al. Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung health. Lancet Glob Health. 2020;8(10):e1316\u201325.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"26743_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/infdis\/jiac227","volume":"226","author":"JM Langley","year":"2022","unstructured":"Langley JM, Bianco V, Domachowske JB, et al. Incidence of respiratory syncytial virus lower respiratory tract infections during the first 2 years of life: a prospective study across diverse global settings. J Infect Dis. 2022;226(3):374\u201385.","journal-title":"J Infect Dis"},{"issue":"10","key":"26743_CR24","doi-asserted-by":"publisher","first-page":"e1611","DOI":"10.1016\/S2214-109X(24)00269-9","volume":"12","author":"RSV GOLD\u2014ICU Network collaborators","year":"2024","unstructured":"RSV GOLD\u2014ICU Network collaborators. Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries: the RSV GOLD-ICU Network study. Lancet Glob Health. 2024;12(10):e1611\u20139.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"26743_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(23)00630-8","volume":"24","author":"B Cong","year":"2024","unstructured":"Cong B, Ko\u00e7 U, Bandeira T, et al. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis. Lancet Infect Dis. 2024;24(4):361\u201374.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"26743_CR26","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1097\/INF.0000000000003980","volume":"42","author":"S Zven","year":"2023","unstructured":"Zven S, Dorr M, Malloy AMW, et al. Predicting the RSV surge: pediatric RSV patterns of the COVID pandemic. Pediatr Infect Dis J. 2023;42(9):e349\u201351.","journal-title":"Pediatr Infect Dis J"},{"key":"26743_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1200617","volume":"13","author":"MC Yang","year":"2023","unstructured":"Yang MC, Su YT, Chen PH, et al. Changing patterns of infectious diseases in children during the COVID-19 pandemic. Front Cell Infect Microbiol. 2023;13:1200617.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"26743_CR28","doi-asserted-by":"publisher","first-page":"010408","DOI":"10.7189\/jogh.05.010408","volume":"5","author":"T Shi","year":"2015","unstructured":"Shi T, McLean K, Campbell H, et al. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health. 2015;5(1):010408.","journal-title":"J Glob Health"},{"issue":"3","key":"26743_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmi.2024.10.023","volume":"31","author":"R Miyakawa","year":"2025","unstructured":"Miyakawa R, Zhang H, Brooks WA, et al. Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience. Clin Microbiol Infect. 2025;31(3):441\u201350.","journal-title":"Clin Microbiol Infect"},{"issue":"10458","key":"26743_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(24)01699-4","volume":"404","author":"C Pecenka","year":"2024","unstructured":"Pecenka C, Sparrow E, Feikin DR, et al. Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children. Lancet. 2024;404(10458):1157\u201370.","journal-title":"Lancet"},{"issue":"6","key":"26743_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/irv.12672","volume":"14","author":"S Broor","year":"2020","unstructured":"Broor S, Campbell H, Hirve S, et al. Leveraging the global influenza surveillance and response system for global respiratory syncytial virus surveillance-opportunities and challenges. Influenza Other Respir Viruses. 2020;14(6):622\u20139.","journal-title":"Influenza Other Respir Viruses"},{"key":"26743_CR32","unstructured":"World Health Organization. WHO Strategy to Pilot Global Respiratory Syncytial Virus Surveillance Based on the Global Influenza Surveillance and Response System. 2017. https:\/\/iris.who.int\/bitstream\/handle\/10665\/259853\/9789241513203-eng.pdf?sequence=1 (accessed 18 Mar 2025)."},{"key":"26743_CR33","unstructured":"World Health Organization. Progress of respiratory syncytial virus surveillance and disease burden estimation based on the Global Influenza Surveillance and Response System. 2024. https:\/\/iris.who.int\/bitstream\/handle\/10665\/380108\/B09163-eng.pdf?sequence=1 (accessed 18 Mar 2025)."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26743-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26743-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26743-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:44:58Z","timestamp":1781635498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26743-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26743"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26743-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"CSL conducted the majority of the work for this study while a doctoral candidate at Johns Hopkins University and as a paid consultant at the World Health Organization. At the time of publication, she is employed by Pfizer, Inc. HZ reports grants from WHO during the conduct of this study. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1059"}}